iNO
Showing 1 - 25 of 255
Healthy Volunteers Trial in Philadelphia (INO-A002, CELLECTRA® 2000, Dengue Fever Antibodies (IgG))
Completed
- Healthy Volunteers
- INO-A002
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 7, 2022
Lassa Fever Trial in Legon (INO-4500, CELLECTRA™ 2000, Placebo)
Completed
- Lassa Fever
- INO-4500
- +2 more
-
Legon, Accra, GhanaNoguchi Memorial Institute for Medical Research, University of G
Nov 18, 2022
Infective Complications and Outcome of ALL Treated With INO
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- (no location specified)
Aug 29, 2023
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Trial in Jordan, Kenya, Lebanon (INO-4700, Placebo, CELLECTRA™ 2000)
Completed
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
- INO-4700
- +2 more
-
Irbid, Jordan
- +5 more
Jan 27, 2023
Pulmonary Embolism, Pulmonary Embolism Subacute Massive Trial in Los Angeles (inhaled nitric oxide (iNO))
Withdrawn
- Pulmonary Embolism
- Pulmonary Embolism Subacute Massive
- inhaled nitric oxide (iNO)
-
Los Angeles, CaliforniaRonald Reagan UCLA Medical Center
May 11, 2022
HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500
Recruiting
- HIV-1-infection
- INO-6160, 2 mg
- Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
-
New York, New York
- +2 more
Apr 13, 2023
Inhaled Nitric Oxide Responsiveness in Patients With PPHN
Withdrawn
- PPHN
- Hypoxic Respiratory Failure
- (no location specified)
Sep 12, 2023
Coronavirus Infection, SARS-CoV 2 Trial in Seongnam-si, Seoul (biological, device, other)
Completed
- Coronavirus Infection
- SARS-CoV 2
- INO-4800
- +2 more
-
Seongnam-si, Gyeonggi-do, Korea, Republic of
- +1 more
Jul 14, 2022
Coronavirus Infection, COVID-19, Pneumonia, Viral Trial (iNO (inhaled nitric oxide) delivered via the INOpulse Delivery System)
No longer available
- Coronavirus Infection
- +2 more
- iNO (inhaled nitric oxide) delivered via the INOpulse Delivery System
- (no location specified)
Aug 9, 2022
Glioblastoma Trial in United States (biological, radiation, drug)
Active, not recruiting
- Glioblastoma
- INO-5401
- +4 more
-
Duarte, California
- +20 more
Aug 8, 2022
Dyspnea, Pulmonary Embolism Trial in Kingston (Nitric Oxide, Placebo)
Recruiting
- Dyspnea
- Pulmonary Embolism
- Nitric Oxide
- Placebo
-
Kingston, Ontario, CanadaRespiratory Investigation Unit, Kingston General Hospital
Sep 8, 2022
BRCA1/2 Mutation Trial in Philadelphia (INO-5401, INO-9012, Cellectra 2000)
Recruiting
- BRCA1/2 Mutation
- INO-5401
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Dec 7, 2021
ALL, MRD-positive, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Inotuzumab Ozogamicin)
Recruiting
- ALL
- +2 more
- Inotuzumab Ozogamicin
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jul 14, 2023
Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine
Active, not recruiting
- Chronic Hepatitis
- Hepatitis C Infection
- Electroporation-Mediated Plasmid DNA Vaccine Therapy
- +4 more
-
Jacksonville, Florida
- +4 more
Sep 20, 2022
HCC Trial in Baltimore, New York, Auckland (biological, drug, device)
Recruiting
- HCC
- GNOS-PV02
- +3 more
-
Baltimore, Maryland
- +2 more
Apr 26, 2022
Congenital Diaphragmatic Hernia Trial in Houston (Inhaled Nitric Oxide (iNO) use, De-implementation of Inhaled Nitric Oxide
Not yet recruiting
- Congenital Diaphragmatic Hernia
- Inhaled Nitric Oxide (iNO) use
- De-implementation of Inhaled Nitric Oxide (iNO) use
-
Houston, TexasThe University of Texas Health Science Center at Houston
Jan 27, 2022
COPD, Pulmonary Hypertension, COPD Trial in Edegem (Inhaled Nitric Oxide 30mcg/kg IBW/hr)
Terminated
- COPD
- +2 more
- Inhaled Nitric Oxide 30mcg/kg IBW/hr
-
Edegem, BelgiumAntwerp University Hospital
Aug 9, 2022
Acute Respiratory Distress Syndrome, Ventilation Perfusion Mismatch Trial (Nitric Oxide)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Ventilation Perfusion Mismatch
- Nitric Oxide
- (no location specified)
Apr 12, 2023
Cerebrovascular Disorders, Acute Cerebrovascular Disease Trial in Charlotte (iNO)
Not yet recruiting
- Cerebrovascular Disorders
- Acute Cerebrovascular Disease
- iNO
-
Charlotte, North Carolina
- +1 more
May 12, 2023
Traumatic Brain Injury Trial in Philadelphia (inhaled nitric oxide)
Not yet recruiting
- Traumatic Brain Injury
- inhaled nitric oxide
-
Philadelphia, PennsylvaniaPenn Presbyterian Medical Center
Nov 8, 2022
Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA
Active, not recruiting
- Human Papillomavirus-16 Positive
- +20 more
- DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
- Durvalumab
-
Houston, TexasM D Anderson Cancer Center
Feb 11, 2022
Stroke Trial in Philadelphia (Nitric Oxide)
Active, not recruiting
- Stroke
- Nitric Oxide
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Nov 23, 2022
Cardiac Arrest Trial in Toronto (inhaled nitric oxide (iNO), Sham)
Recruiting
- Cardiac Arrest
- inhaled nitric oxide (iNO)
- Sham
-
Toronto, Ontario, Canada
- +3 more
May 11, 2023